Pregledni rad
https://doi.org/10.20471/sept.2026.62.02.07
Xenon as an Alternative to Antidepressants in the Therapy of Post-Traumatic Stress Disorder
Oleksandra Skavinska
; Ekspertno-analitički medicinski centar za molekularnu genetiku, Nacionalno sveučilište zdravstva Ukrajine „Šupik“, Kijev, Ukrajina
Liliia Fishchuk
; Ekspertno-analitički medicinski centar za molekularnu genetiku, Nacionalno sveučilište zdravstva Ukrajine „Šupik“, Kijev, Ukrajina
*
Makar Sheiko
; Klinika za neuroimunologiju „Vivere“, Kijev, Ukrajina
Volodymyr Stefanyshyn
; Klinika za neuroimunologiju „Vivere“, Kijev, Ukrajina
Zoia Rossokha
; Ekspertno-analitički medicinski centar za molekularnu genetiku, Nacionalno sveučilište zdravstva Ukrajine „Šupik“, Kijev, Ukrajina
Natalia Gorovenko
; Odjel za medicinsku i laboratorijsku genetiku, Nacionalno sveučilište zdravstva Ukrajine „Šupik“, Kijev, Ukrajina
* Dopisni autor.
Sažetak
Aim: To explore recent studies and synthesize current knowledge to use xenon gas as a potential treatment for post-traumatic stress disorder (PTSD). Materials and Methods: For this non-systematic narrative review, we searched PubMed, Scopus and Google Scholar for peer-reviewed studies on xenon's potential for PTSD. Results: Xenon's main mechanism of action appears to be N-methyl-D-aspartate receptor blockade. Through this mechanism, xenon exhibits neuroprotective, antidepressant, and anxiolytic effects, and it may also influence memory reconsolidation. In animal studies, xenon reduced the types of brain and behavior changes observed after trauma. Moreover, unlike some other drugs that targeting the same receptors (e.g., ketamine), xenon does not appear to cause serious side effects. Conclusion: Preliminary evidence suggests that xenon may be a safe and effective treatment for PTSD. Further studies are needed to confirm its efficacy and safety.
Ključne riječi
ntidepressive agents; neuroprotective agents; receptors, n-methyl-d-aspartate; stress disorders, post-traumatic; xenon
Hrčak ID:
352589
URI
Datum izdavanja:
16.10.2026.
Posjeta: 0 *